Comments
Loading...

Monopar Therapeutics

MNPRNASDAQ
Logo brought to you by Benzinga Data
$19.71
0.713.74%
At close: -
$19.51
-0.2-1.01%
After Hours: 4:20 PM EDT

Monopar Therapeutics (NASDAQ:MNPR) Stock Quotes, Forecast and News Summary

Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Aug
1
Oct
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$19.03
Close$19.71
Volume / Avg.48.40K / 1.24M
Day Range$19.03 - $20.00
52 Wk Range1.37 - 38.50
Market Cap$102.97M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
63
Short Interest
3.21%
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MNPR
CABA

FAQ

Q

How do I buy Monopar Therapeutics (MNPR) stock?

A

You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Monopar Therapeutics (MNPR) competitors?

Q

What is the forecast, or price target, for Monopar Therapeutics (MNPR) stock?

A

Monopar Therapeutics has a consensus price target of $21.80.

Q

What is the current price for Monopar Therapeutics (MNPR)?

A

The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $19.51 last updated November 21, 2024 at 4:20 PM EST.

Q

Does Monopar Therapeutics (MNPR) pay a dividend?

A

There are no upcoming dividends for Monopar Therapeutics.

Q

When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?

A

Monopar Therapeutics’s Q3 earnings are confirmed for Friday, November 8, 2024.

Q

Is Monopar Therapeutics (MNPR) going to split?

A

There is no upcoming split for Monopar Therapeutics.

Q

What sector and industry does Monopar Therapeutics (MNPR) operate in?

A

Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch